Raymond James Financial Services Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.63M | Buy |
84,193
+7,262
| +9% | +$485K | 0.01% | 1156 |
|
|
2024
Q2 | $9.14M | Buy |
76,931
+10,259
| +15% | +$1.22M | 0.01% | 866 |
|
|
2024
Q1 | $7.1M | Buy |
66,672
+8,334
| +14% | +$888K | 0.01% | 959 |
|
|
2023
Q4 | $5.8M | Buy |
58,338
+1,554
| +3% | +$155K | 0.01% | 1001 |
|
|
2023
Q3 | $5.87M | Sell |
56,784
-5,672
| -9% | -$586K | 0.01% | 937 |
|
|
2023
Q2 | $7.59M | Buy |
62,456
+9,001
| +17% | +$1.09M | 0.01% | 824 |
|
|
2023
Q1 | $8.21M | Buy |
53,455
+9,386
| +21% | +$1.44M | 0.02% | 775 |
|
|
2022
Q4 | $7.92M | Sell |
44,069
-111
| -0.3% | -$19.9K | 0.02% | 753 |
|
|
2022
Q3 | $5.22M | Sell |
44,180
-1,550
| -3% | -$183K | 0.01% | 893 |
|
|
2022
Q2 | $6.53M | Sell |
45,730
-37,228
| -45% | -$5.32M | 0.01% | 806 |
|
|
2022
Q1 | $14.3M | Buy |
82,958
+2,181
| +3% | +$376K | 0.03% | 553 |
|
|
2021
Q4 | $20.5M | Sell |
80,777
-29,660
| -27% | -$7.53M | 0.04% | 448 |
|
|
2021
Q3 | $42.5M | Sell |
110,437
-10,105
| -8% | -$3.89M | 0.09% | 241 |
|
|
2021
Q2 | $28.3M | Buy |
120,542
+43,594
| +57% | +$10.2M | 0.06% | 330 |
|
|
2021
Q1 | $10.1M | Buy |
76,948
+14,044
| +22% | +$1.84M | 0.02% | 622 |
|
|
2020
Q4 | $6.57M | Sell |
62,904
-26,192
| -29% | -$2.74M | 0.02% | 719 |
|
|
2020
Q3 | $6.3M | Sell |
89,096
-650
| -0.7% | -$46K | 0.02% | 672 |
|
|
2020
Q2 | $5.76M | Buy |
89,746
+29,227
| +48% | +$1.88M | 0.02% | 649 |
|
|
2020
Q1 | $1.81M | Buy |
60,519
+26,569
| +78% | +$796K | 0.01% | 925 |
|
|
2019
Q4 | $664K | Buy |
33,950
+3,610
| +12% | +$70.6K | ﹤0.01% | 1790 |
|
|
2019
Q3 | $483K | Buy |
30,340
+15,803
| +109% | +$252K | ﹤0.01% | 1923 |
|
|
2019
Q2 | $213K | Buy |
+14,537
| New | +$213K | ﹤0.01% | 2498 |
|